Blend Labs officer plans $107K stock sale

Rhea-AI Filing Summary

Blend Labs, Inc. (BLND) received a notice under Rule 144 that officer Venkatramani Srinivasan intends to sell shares of the company’s common stock through Charles Schwab & Co., Inc. The planned sale relates to shares from restricted stock lapses granted as equity compensation in 2026.

Key Figures

Shares covered by Rule 144 notice: 74,705 shares Aggregate market value: $106,852.00 Restricted stock lapse on February 20, 2026: 49,803 shares +2 more

5 metrics

Shares covered by Rule 144 notice 74,705 shares Total Blend Labs common shares intended for resale under the notice

Aggregate market value $106,852.00 Aggregate market value of the 74,705 Blend Labs shares listed in the notice

Restricted stock lapse on February 20, 2026 49,803 shares Blend Labs restricted stock lapse tied to equity compensation

Restricted stock lapse on May 20, 2026 12,451 shares Blend Labs restricted stock lapse tied to equity compensation

Restricted stock lapse on August 20, 2026 12,451 shares Blend Labs restricted stock lapse tied to equity compensation

Key Terms

Rule 144, Restricted Stock Lapse, Equity Compensation

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Lapse financial

"Common | 02/20/2026 | Restricted Stock Lapse | BLEND LABS, INC."

Equity Compensation financial

"02/20/2026 | Equity Compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing mean for Blend Labs, Inc. (BLND)?

The filing states that an officer of Blend Labs, Inc. has notified the SEC of an intended resale of common stock under Rule 144. It relates to previously issued equity compensation and does not represent a new issuance of shares by Blend Labs.

How many Blend Labs (BLND) shares are covered by this Rule 144 notice?

The notice covers an intended resale of 74,705 shares of Blend Labs common stock. This total matches the sum of 49,803; 12,451; and 12,451 shares tied to restricted stock lapses in 2026.

What is the approximate aggregate market value of the BLND shares in this Form 144?

The filing lists an aggregate market value of about $106,852.00 for the 74,705 Blend Labs common shares covered by the Rule 144 notice, based on the filer’s stated figures.

Who is selling Blend Labs (BLND) shares under this Form 144?

The person for whose account the securities are to be sold is Venkatramani Srinivasan, identified as an officer of Blend Labs, Inc. The shares will be sold through Charles Schwab & Co., Inc., according to the notice.

What is the source of the BLND shares being sold under Rule 144?

The shares come from restricted stock lapses granted as equity compensation by Blend Labs, Inc., with vesting events dated February 20, 2026; May 20, 2026; and August 20, 2026, corresponding to 49,803; 12,451; and 12,451 shares respectively.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/11/2026 - 04:39 PM Accepted by SEC EDGAR 09/11/2026 - 04:38 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002050301
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Blend Labs, Inc.
SEC File Number	001-40599
Address of Issuer	7250 REDWOOD BLVD., SUITE 300 NOVATO CALIFORNIA 94945
Phone	(650) 550-4810
Name of Person for Whose Account the Securities are To Be Sold	Venkatramani Srinivasan
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	74705	106852.00	233256934	09/11/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/20/2026	Restricted Stock Lapse	BLEND LABS, INC.			49803	02/20/2026	Equity Compensation
Common	05/20/2026	Restricted Stock Lapse	BLEND LABS, INC.			12451	05/20/2026	Equity Compensation
Common	08/20/2026	Restricted Stock Lapse	BLEND LABS, INC.			12451	08/20/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/11/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/12/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Srinivasan Venkatramani
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)